NEW EUROPEAN MEDICAL DEVICE REGULATION (MDR 2017/745)

MTA is a Contract Research Organization (CRO). As an independent organization, MTA supports the identification and development processes of promising therapeutic approaches proposed by research institutes, universities, pharmaceutical, biomedical and tech-med companies offering support in the product’s development and quality certified assessment of new medical strategies in the clinical setting.

MTA is more than a CRO because it represents an academic-rooted organisation supporting medical products development ensuring planning, management and coordination of clinical studies and clinical services at certified international quality standards.

Because your project is unique! Our mission is to provide tailored services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life.

For the following activities:
Planning, management, coordination and monitoring of national and international clinical trials with medicinal products, medical devices, diagnostics, dietary supplements and biotechnological products. Development and provision of educational courses concerning clinical research, scientific, healthcare and pharmaceutical fields.